Magnetic Resonance Imaging of the Entorhinal Cortex and Hippocampus in Mild Cognitive Impairment and Alzheimer's Disease

Overview

Journal J Neurol Neurosurg Psychiatry

Publisher BMJ Publishing Group

Specialties Neurology
Neurosurgery
Psychiatry

Date 2001 Sep 19

PMID 11561025

Citations 265

Authors

A T Du

N Schuff

D AMEND

M P Laakso

Y Y Hsu

W J Jagust

K Yaffe

J H Kramer

B Reed

D Norman

H C Chui

M W Weiner

Affiliations

Soon will be listed here.

Abstract

Objectives: To explore volume changes of the entorhinal cortex (ERC) and hippocampus in mild cognitive impairment (MCI) and Alzheimer's disease (AD) compared with normal cognition (NC); to determine the powers of the ERC and the hippocampus for discrimination between these groups.

Methods: This study included 40 subjects with NC, 36 patients with MCI, and 29 patients with AD. Volumes of the ERC and hippocampus were manually measured based on coronal T1 weighted MR images. Global cerebral changes were assessed using semiautomatic image segmentation.

Results: Both ERC and hippocampal volumes were reduced in MCI (ERC 13%, hippocampus 11%, p<0.05) and AD (ERC 39%, hippocampus 27%, p<0.01) compared with NC. Furthermore, AD showed greater volume losses in the ERC than in the hippocampus (p<0.01). In addition, AD and MCI also had cortical grey matter loss (p< 0.01) and ventricular enlargement (p<0.01) when compared with NC. There was a significant correlation between ERC and hippocampal volumes in MCI and AD (both p<0.001), but not in NC. Using ERC and hippocampus together improved discrimination between AD and CN but did not improve discrimination between MCI and NC. The ERC was better than the hippocampus for distinguishing MCI from AD. In addition, loss of cortical grey matter significantly contributed to the hippocampus for discriminating MCI and AD from NC.

Conclusions: Volume reductions in the ERC and hippocampus may be early signs of AD pathology that can be measured using MRI.

Citing Articles

Hippocampal volume asymmetry in Alzheimer disease: A systematic review and meta-analysis.

Pusparani Y, Lin C, Jan Y, Lin F, Liau B, Alex J Medicine (Baltimore). 2025; 104(10):e41662.

PMID: 40068028 PMC: 11903023. DOI: 10.1097/MD.0000000000041662.

An experimental framework for conjoint measures of olfaction, navigation, and motion as pre-clinical biomarkers of Alzheimer's disease.

Biljman K, Gozes I, Lam J, Li V J Alzheimers Dis Rep. 2025; 8(1):1722-1744.

PMID: 40034341 PMC: 11863766. DOI: 10.1177/25424823241307617.

Hippocampal Subfield Volume in Relation to Cerebrospinal Fluid Amyloid-ß in Early Alzheimer's Disease: Diagnostic Utility of 7T MRI.

Adeyemi O, Gowland P, Bowtell R, Mougin O, Hosseini A Eur J Neurol. 2025; 32(2):e70076.

PMID: 39921301 PMC: 11806197. DOI: 10.1111/ene.70076.

Unveiling mitochondria as central components driving cognitive decline in alzheimer's disease through cross-transcriptomic analysis of hippocampus and entorhinal cortex microarray datasets.

Sonsungsan P, Aimauthon S, Sriwichai N, Namchaiw P Heliyon. 2024; 10(20):e39378.

PMID: 39498000 PMC: 11534180. DOI: 10.1016/j.heliyon.2024.e39378.

Adaptive 3DCNN-based Interpretable Ensemble Model for Early Diagnosis of Alzheimer's Disease.

Pan D, Luo G, Zeng A, Zou C, Liang H, Wang J IEEE Trans Comput Soc Syst. 2024; 11(1):247-266.

PMID: 39239536 PMC: 11374388. DOI: 10.1109/tcss.2022.3223999.

References

Geroldi C, Pihlajamaki M, Laakso M, DeCarli C, Beltramello A, Bianchetti A . APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurology. 1999; 53(8):1825-32. DOI: 10.1212/wnl.53.8.1825. View

Killiany R, Gomez-Isla T, Moss M, Kikinis R, Sandor T, Jolesz F . Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol. 2000; 47(4):430-9. View

Xu Y, Jack Jr C, OBrien P, Kokmen E, Smith G, Ivnik R . Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology. 2000; 54(9):1760-7. DOI: 10.1212/wnl.54.9.1760. View

Kesslak J, Nalcioglu O, Cotman C . Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology. 1991; 41(1):51-4. DOI: 10.1212/wnl.41.1.51. View

Jack Jr C, Petersen R, OBrien P, Tangalos E . MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology. 1992; 42(1):183-8. DOI: 10.1212/wnl.42.1.183. View

Pearlson G, Harris G, Powers R, Barta P, Camargo E, Chase G . Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease. Arch Gen Psychiatry. 1992; 49(5):402-8. DOI: 10.1001/archpsyc.1992.01820050066012. View

Watson C, Andermann F, Gloor P, Jones-Gotman M, Peters T, Evans A . Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging. Neurology. 1992; 42(9):1743-50. DOI: 10.1212/wnl.42.9.1743. View

Braak H, Braak E, Bohl J . Staging of Alzheimer-related cortical destruction. Eur Neurol. 1993; 33(6):403-8. DOI: 10.1159/000116984. View

Convit A, de Leon M, Tarshish C, De Santi S, Kluger A, Rusinek H . Hippocampal volume losses in minimally impaired elderly. Lancet. 1995; 345(8944):266. DOI: 10.1016/s0140-6736(95)90265-1. View

10.

Laakso M, Soininen H, Partanen K, Helkala E, Hartikainen P, Vainio P . Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions. J Neural Transm Park Dis Dement Sect. 1995; 9(1):73-86. DOI: 10.1007/BF02252964. View

11.

Mackay S, Ezekiel F, DI Sclafani V, Meyerhoff D, GERSON J, Norman D . Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging. Radiology. 1996; 198(2):537-45. PMC: 2733362. DOI: 10.1148/radiology.198.2.8596863. View

12.

Fox N, Warrington E, Stevens J, Rossor M . Atrophy of the hippocampal formation in early familial Alzheimer's disease. A longitudinal MRI study of at-risk members of a family with an amyloid precursor protein 717Val-Gly mutation. Ann N Y Acad Sci. 1996; 777:226-32. DOI: 10.1111/j.1749-6632.1996.tb34423.x. View

13.

Mackay S, Meyerhoff D, Constans J, Norman D, Fein G, Weiner M . Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging. Arch Neurol. 1996; 53(2):167-74. PMC: 2733342. DOI: 10.1001/archneur.1996.00550020079018. View

14.

Sandson T, OConnor M, Sperling R, Edelman R, Warach S . Noninvasive perfusion MRI in Alzheimer's disease: a preliminary report. Neurology. 1996; 47(5):1339-42. DOI: 10.1212/wnl.47.5.1339. View

15.

Tanabe J, AMEND D, Schuff N, DiSclafani V, Ezekiel F, Norman D . Tissue segmentation of the brain in Alzheimer disease. AJNR Am J Neuroradiol. 1997; 18(1):115-23. PMC: 8337876. View

16.

Pantel J, Schroder J, Schad L, Friedlinger M, Knopp M, Schmitt R . Quantitative magnetic resonance imaging and neuropsychological functions in dementia of the Alzheimer type. Psychol Med. 1997; 27(1):221-9. DOI: 10.1017/s003329179600431x. View

17.

Kaye J, Swihart T, Howieson D, Dame A, Moore M, Karnos T . Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology. 1997; 48(5):1297-304. DOI: 10.1212/wnl.48.5.1297. View

18.

Convit A, de Leon M, Tarshish C, De Santi S, Tsui W, Rusinek H . Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiol Aging. 1997; 18(2):131-8. DOI: 10.1016/s0197-4580(97)00001-8. View

19.

Jack Jr C, Petersen R, Xu Y, Waring S, OBrien P, Tangalos E . Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology. 1997; 49(3):786-94. PMC: 2730601. DOI: 10.1212/wnl.49.3.786. View

20.

Kidron D, Black S, Stanchev P, Buck B, Szalai J, Parker J . Quantitative MR volumetry in Alzheimer's disease. Topographic markers and the effects of sex and education. Neurology. 1997; 49(6):1504-12. DOI: 10.1212/wnl.49.6.1504. View